Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 9 of 9 drugs
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ambrisentan | [3] Ambrisentan Ambrisentan; Letairis; VOLIBRIS | [1] Ambrisentan
Ambrisentan
💬1. Ambrisentan
| [1] EDNRA EDNRA 💬1. Ambrisentan
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [7] 51 51, 84, 85, 86, 88, 210, 211 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Ascorbic acid | [4] Acidum ascorbicum Acidum ascorbicum; Ascorbic Acid; Iron; Vitamin C | [1] Ascorbic acid
Ascorbic acid
💬2. Ascorbic acid
| - | - | [8] 10 10, 97, 192, 206, 210, 211, 212, 298 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Bosentan | [2] BOSENTAN BOSENTAN; TRACLEER | [2] Bosentan
Bosentan
,Bosentan 💬 | [2] EDNRA EDNRA,EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Methylprednisolone | [4] Medrol Medrol; Methylprednisolon; METHYLPREDNISOLONE; Methylprednisolone acetate | [1] Methylprednisolone
Methylprednisolone
💬4. Methylprednisolone
| [1] NR3C1 NR3C1 💬4. Methylprednisolone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 [46] 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, ... 4. Methylprednisolone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Methylprednisolone hemisuccinate | [4] Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate; METHYLPREDNISOLONE SODIUM SUCCINATE; Methylprednisolone succinate; SOLU-MEDROL [4] Methylprednisolone hemisuccinate; METHYLPREDNISOLONE SODIUM SUCCINATE; Methylprednisolone succin ... | [1] Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinate
💬5. Methylprednisolone hemisuccinate
| [1] NR3C1 NR3C1 💬5. Methylprednisolone hemisuccinate
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 13 13, 49, 50, 51, 53, 97, 211 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Nitrogen | [1] Nitrogen Nitrogen | [1] Nitrogen
Nitrogen
💬6. Nitrogen
| - | - | [5] 5 5, 6, 17, 211, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Oxandrolone | [1] Oxandrolone Oxandrolone | [1] Oxandrolone
Oxandrolone
💬7. Oxandrolone
| [1] AR AR 💬7. Oxandrolone
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate canc ... | [2] 211 211, 285 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Poractant alfa | [1] Curosurf Curosurf | [1] Poractant alfa
Poractant alfa
💬8. Poractant alfa
| - | - | [1] 211 211 💬8. Poractant alfa
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Sildenafil | [6] Mysildecard Mysildecard; Revatio; Sildenafil; Sildenafil citrate; SILDENAFILO; VIAGRA | [1] Sildenafil
Sildenafil
💬9. Sildenafil
| [1] PDE5A PDE5A 💬9. Sildenafil
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬9. Sildenafil
|